Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to -$849000.0.

  • Solesence's Change in Accured Expenses fell 16021.28% to -$849000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 43.14%. This contributed to the annual value of $4.0 million for FY2024, which is 283150.68% up from last year.
  • As of Q3 2025, Solesence's Change in Accured Expenses stood at -$849000.0, which was down 16021.28% from $882000.0 recorded in Q2 2025.
  • In the past 5 years, Solesence's Change in Accured Expenses registered a high of $1.6 million during Q4 2024, and its lowest value of -$849000.0 during Q3 2025.
  • In the last 5 years, Solesence's Change in Accured Expenses had a median value of $302000.0 in 2021 and averaged $255368.4.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first plummeted by 126666.67% in 2021, then skyrocketed by 73436.29% in 2024.
  • Quarter analysis of 5 years shows Solesence's Change in Accured Expenses stood at -$310000.0 in 2021, then decreased by 4.52% to -$324000.0 in 2022, then rose by 20.06% to -$259000.0 in 2023, then surged by 734.36% to $1.6 million in 2024, then tumbled by 151.67% to -$849000.0 in 2025.
  • Its last three reported values are -$849000.0 in Q3 2025, $882000.0 for Q2 2025, and $419000.0 during Q1 2025.